DK7191D0 - Topisk salve - Google Patents

Topisk salve

Info

Publication number
DK7191D0
DK7191D0 DK007191A DK7191A DK7191D0 DK 7191 D0 DK7191 D0 DK 7191D0 DK 007191 A DK007191 A DK 007191A DK 7191 A DK7191 A DK 7191A DK 7191 D0 DK7191 D0 DK 7191D0
Authority
DK
Denmark
Prior art keywords
pct
sec
date
topical
salve
Prior art date
Application number
DK007191A
Other languages
English (en)
Other versions
DK7191A (da
Inventor
Gabriele Flender
Original Assignee
Weck Wolfgang
Gabriele Flender
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Weck Wolfgang, Gabriele Flender filed Critical Weck Wolfgang
Publication of DK7191D0 publication Critical patent/DK7191D0/da
Publication of DK7191A publication Critical patent/DK7191A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK007191A 1988-10-31 1991-01-15 Topisk salve DK7191A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3836971A DE3836971C1 (da) 1988-10-31 1988-10-31
PCT/EP1989/001276 WO1990004967A2 (de) 1988-10-31 1989-10-26 Topische salbe

Publications (2)

Publication Number Publication Date
DK7191D0 true DK7191D0 (da) 1991-01-15
DK7191A DK7191A (da) 1991-06-04

Family

ID=6366210

Family Applications (1)

Application Number Title Priority Date Filing Date
DK007191A DK7191A (da) 1988-10-31 1991-01-15 Topisk salve

Country Status (11)

Country Link
US (1) US5179086A (da)
EP (2) EP0440715A1 (da)
JP (1) JPH0647544B2 (da)
AT (1) ATE84216T1 (da)
CA (1) CA2001797A1 (da)
DE (2) DE3836971C1 (da)
DK (1) DK7191A (da)
ES (1) ES2053907T3 (da)
GR (1) GR3007370T3 (da)
PT (1) PT92148B (da)
WO (1) WO1990004967A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705030A1 (fr) * 1993-05-11 1994-11-18 Biodev Utilisation de composés stéroliques pour la fabrication d'un médicament anti-inflammatoire.
US5888984A (en) 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US5444092A (en) * 1994-07-20 1995-08-22 Collins; Jerry Method and composition for treating psoriasis
GB9814527D0 (en) * 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
ES2318906T3 (es) * 1998-11-13 2009-05-01 Cyclacel Limited Vectores de transposicion derivados de helice 3 de homeodominio de antennapedia.
WO2000044367A2 (en) 1999-02-01 2000-08-03 Dermal Research Laboratories, Inc. A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
TNSN02063A1 (en) * 2001-07-07 2005-12-23 Egyptian Natural Oil Co Natoil The medical effect of jojoba oil
US7048914B2 (en) * 2002-12-12 2006-05-23 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
US20050002884A1 (en) * 2003-07-02 2005-01-06 Marsella Jefferson Hair treatment compositions
US7374754B2 (en) * 2003-09-02 2008-05-20 Essential Skincare, Llc Use of placental alkaline phosphatase to promote skin cell proliferation
US8455016B2 (en) * 2004-03-12 2013-06-04 Melbj Holdings, Llc Treatment for meibomian gland dysfunction or obstruction
WO2007075199A1 (en) * 2005-12-28 2007-07-05 Zoltan Laboratories Llc Use of alkaline phosphatase to maintain healthy tissue mass in mammals
CA2735968A1 (en) * 2008-12-24 2010-07-01 Biomedcore Inc. Method for producing liposome and method for dissolving cholesterol
WO2011136288A1 (ja) 2010-04-28 2011-11-03 久光製薬株式会社 ドネペジル含有経皮吸収製剤
EP2564873A4 (en) 2010-04-28 2013-11-06 Hisamitsu Pharmaceutical Co MEANS FOR THE SUPPRESSION OF SKIN IRRITATIONS AND TRANSDERMAL PREPARATION THEREOF
JP5462421B2 (ja) 2011-10-26 2014-04-02 久光製薬株式会社 オキシブチニン含有経皮吸収製剤
US9717741B2 (en) 2012-10-11 2017-08-01 Anaplasi Pharmaceuticals Llc Method and compositions for treating psoriasis
US9987361B1 (en) 2014-12-29 2018-06-05 Noven Pharmaceuticals, Inc. Compositions and method for sustained drug delivery by active transdermal technology
WO2020091703A1 (en) * 2018-11-01 2020-05-07 Yeditepe Universitesi A medicine for treatment of psoriasis and production method thereof
GB201918752D0 (en) * 2019-12-18 2020-01-29 Ucl Business Plc New therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE523144C (de) * 1927-09-11 1931-04-20 Friedrich Passek Verfahren zur Herstellung wasserreicher Cholesterinloesungen
DE638839C (de) * 1935-01-15 1936-11-24 Chem Fab Promonta G M B H Verfahren zur Herstellung waessrig-alkoholischer Cholesterinloesungen
FR928337A (fr) * 1946-05-20 1947-11-25 Procédé d'obtention de solutions stables de cholestérine, en vue de la préparation de produits cosmétiques et de beauté
FR2485921A1 (fr) * 1980-07-01 1982-01-08 Oreal Composition cosmetique a base d'une dispersion aqueuse de spherules lipidiques
IT8221553A0 (it) * 1982-05-28 1982-05-28 Gruppo Scient Revici Pacelli Composizioni farmaceutiche adattivita' antineoplastica.
DE3225849A1 (de) * 1982-07-07 1984-01-19 Schering Ag Kortikoidhaltige zubereitung zur topischen applikation
FR2568142B1 (da) * 1984-07-26 1989-11-17 Oreal
US4743597A (en) * 1986-01-27 1988-05-10 Javitt Norman B Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases
FR2597346B1 (fr) * 1986-04-22 1989-08-18 Oreal Procede pour faciliter la formation de niosomes en dispersion dans une phase aqueuse et pour ameliorer leur stabilite et leur taux d'encapsulation, et dispersions correspondantes.

Also Published As

Publication number Publication date
GR3007370T3 (da) 1993-07-30
US5179086A (en) 1993-01-12
DE58903222D1 (de) 1993-02-18
DK7191A (da) 1991-06-04
CA2001797A1 (en) 1990-04-30
PT92148B (pt) 1995-06-30
EP0440715A1 (de) 1991-08-14
WO1990004967A2 (de) 1990-05-17
EP0367103A1 (de) 1990-05-09
ES2053907T3 (es) 1994-08-01
DE3836971C1 (da) 1990-05-17
EP0367103B1 (de) 1993-01-07
PT92148A (pt) 1990-05-31
ATE84216T1 (de) 1993-01-15
JPH0647544B2 (ja) 1994-06-22
JPH04501415A (ja) 1992-03-12
WO1990004967A3 (de) 1990-06-28

Similar Documents

Publication Publication Date Title
DK7191D0 (da) Topisk salve
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
ATE189527T1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
PT912176E (pt) Utilizacao de amidas do acido piridil-alcanoico piridil-alcenoico e/ou piridil-alcinico para o tratamento de tumores ou para imunossupressao
DE69328550T2 (de) Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln
NO954320D0 (no) Lyosfærer omfattende gonadotropin
BR9506835A (pt) Acido micofenólico substituído em 6 e derivados
DK0658348T3 (da) Vandige opløsninger af inklusionskomplekser af benzothiophenforbindelser og cyclodextriner
DK71387D0 (da) Terapeutisk middel til behandling af psoriasis
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
DE3786714T2 (de) Therapeutisches Mittel für Hautgeschwüre.
ATE133680T1 (de) Oligosaccharidderivate und deren verwendung in heilmitteln
BG101126A (en) The use of muramylpeptide compounds
ATE179594T1 (de) Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
ATE215084T1 (de) Imidazopyridin-azolidinone
ATE167804T1 (de) Verwendung von nickel und bromide ionen für die behandlung von psoriasis
IT8420213A0 (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi.
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.
DE69807200D1 (de) Inklusionskomplexe in waessriger loesung
NO974687D0 (no) Kondenserte <beta>-carboliner
RO86650B1 (ro) Preparat farmaceutic pentru tratarea dermatozelor
ITRM920516A0 (it) Composizione e suo uso per il trattamento terapeutico di affezioni dermatitiche, particolarmente la psoriasi.
MX9203508A (es) 1,7-difenil-3-metilaza -7-ciano-8-metilnonano para usarse en el tratamiento de enfermedades.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment